An extended trial of symptomatic treatment vs. intensive bisphosphate therapy on the quality of life and clinical outcomes in Paget's Disease. This trial is complete and published. Image PRISM-EZ: is an extended trial of symptomatic treatment vs. intensive bisphosphate therapy on the quality of life and clinical outcomes in Paget's Disease. Chief Investigator: Professor Stuart Ralston Trial Manager: Gina Cranswick Funder: Arthritis Research Campaign, National Association for the Relief of Paget's Disease, The Alliance for Better Bone Health, and Novartis UK. For any queries relating to this trial please contact Gina Cranswick (Trial Manager) on tel: 0131 537 2531 This article was published on 2024-09-24
